Abstract:The value of the Cre-lox system in biology is well-recognized, which is reflected by its widespread use to assess the role of a gene in a specific tissue or cell-type. Not in the least, Cre recombinase expressed under the Pax7 promotor has been invaluable for the study of skeletal muscle stem cell (MuSC) biology. In this study, we aimed to systematically assess the effects of the genetic makeup of Pax7Cre mice and Tamoxifen (Tx) treatment on skeletal muscle regeneration. We demonstrate that Tx treatment does not affect skeletal muscle regeneration at 14 days post injury (d.p.i.) induced by cardiotoxin, but specifically worsened regeneration in two Pax7Cre lines. Pax7 heterozygosity in Pax7Cre mice resulted in a lower body mass and (TA) mass, a higher number of fibers section, and a lower number of Pax7 cells than in Pax7Cre mice, but Tx treatment did not worsen these effects caused by Pax7 haploinsufficiency. , proliferation of Pax7Cre MuSCs was impaired after 4-Hydrotamoxifen (4-OHT) treatment, while cell survival and differentiation remained unaffected. Together with a lower number of nuclei fiber after Tx treatment in Pax7Cre and male Pax7Cre mice, this may suggest an impaired MuSC pool expansion upon Cre activation. Yet, the MuSC pool was maintained in Pax7Cre mice at 14 d.p.i. Overall, our results directly show that Cre recombinase activity has an off-target effect on MuSCs, which warrants the use of Tx-treated Pax7Cre mice as experimental controls in future studies, and demand caution in interpreting data using other controls in previous studies.

Impaired skeletal muscle regeneration induced by Cre recombinase activation in skeletal muscle stem cells